TY  - GEN
AU  - Penka,M
AU  - Schwarz,J
AU  - Ovesná,P
AU  - Cervinek,L
AU  - Dulíček,P
AU  - Pospíšilová,D
AU  - Kissová,J
AU  - Pavlík,T
TI  - [The effectiveness of anagrelide treatment in patients with Ph negative myeloproliferative diseases: influence on the incidence of thrombosis in the data from the Registry of patients with essential thrombocythemia and thrombocythemia associated with other myeloproliferative diseases treated with Thromboreductin® to the end of 2012]
SN  - 0042-773X
PY  - 2015///1016
KW  - Adult
KW  - Aged
KW  - Czech Republic
KW  - Female
KW  - Fibrinolytic Agents
KW  - therapeutic use
KW  - Humans
KW  - Incidence
KW  - Male
KW  - Middle Aged
KW  - Myeloproliferative Disorders
KW  - drug therapy
KW  - Quinazolines
KW  - Registries
KW  - Thrombocythemia, Essential
KW  - Thrombosis
KW  - epidemiology
N1  - Publication Type: Journal Article
ER  -